Danaher Corporation (NYSE:DHR) traded ~1% lower in the premarket on Tuesday as investors reacted to the life sciences company ...

Danaher Corporation’s DHR first-quarter 2025 adjusted earnings of $1.88 per share beat the Zacks Consensus Estimate of $1.62.

Danaher Corporation’s DHR share price has surged by 6.12%, which has investors questioning if this is right time to sell.

Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - ...

Discover key highlights from Danaher's Q1 2025 earnings call, including strong bioprocessing growth, resilient recurring revenues, and strategies to ...

Shares of Danaher Corp. DHR slipped 1.00% to $184.96 Monday, on what proved to be an all-around dismal trading session for ...

The Washington-based company said it had profit of $1.32 per share. Earnings, adjusted for one-time gains and costs, were $1.88 per share. The results surpassed Wall Street expectations. The average ...

Danaher Corp. closed 35.83% below its 52-week high of $281.70, which the company reached on August 1st.

In its fourth quarter 2024 investor letter, Artisan Global Opportunities Fund emphasized stocks such as Danaher Corporation (NYSE:DHR). Danaher Corporation (NYSE:DHR) manufactures and distributes ...

Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting ...

In its first quarter 2025 investor letter, Andvari Associates emphasized stocks such as Danaher Corporation (NYSE:DHR). Danaher Corporation (NYSE:DHR) manufactures and distributes a diverse ...